title: Complement alternative pathway genetic variation and Dengue infection in the Thai population.
abstract: Dengue disease is a mosquito-borne infection caused by Dengue virus. Infection may be asymptomatic or variably manifest as mild Dengue fever (DF) to the most severe form, Dengue haemorrhagic fever (DHF). Mechanisms that influence disease severity are not understood. Complement, an integral component of the immune system, is activated during Dengue infection and the degree of activation increases with disease severity. Activation of the complement alternative pathway is influenced by polymorphisms within activation (factor B rs12614/rs641153, C3 rs2230199) and regulatory [complement factor H (CFH) rs800292] proteins, collectively termed a complotype. Here, we tested the hypothesis that the complotype influences disease severity during secondary Dengue infection. In addition to the complotype, we also assessed two other disease-associated CFH polymorphisms (rs1061170, rs3753394) and a structural polymorphism within the CFH protein family. We did not detect any significant association between the examined polymorphisms and Dengue infection severity in the Thai population. However, the minor allele frequencies of the factor B and C3 polymorphisms were less than 10%, so our study was not sufficiently powered to detect an association at these loci. We were also unable to detect a direct interaction between CFH and Dengue NS1 using both recombinant NS1 and DV2-infected culture supernatants. We conclude that the complotype does not influence secondary Dengue infection severity in the Thai population.
authors.affiliation: Molecular Immunology, Imperial College, London, UK.
authors.forename: R
authors.initials: R
authors.lastname: Kraivong
authors.forename: S
authors.initials: S
authors.lastname: Vasanawathana
authors.forename: W
authors.initials: W
authors.lastname: Limpitikul
authors.forename: P
authors.initials: P
authors.lastname: Malasit
authors.forename: N
authors.initials: N
authors.lastname: Tangthawornchaikul
authors.forename: M
authors.initials: M
authors.lastname: Botto
authors.forename: G R
authors.initials: GR
authors.lastname: Screaton
authors.forename: J
authors.initials: J
authors.lastname: Mongkolsapaya
authors.forename: M C
authors.initials: MC
authors.lastname: Pickering
mesh_terms: D000293:Adolescent; D000328:Adult; D002478:Cells, Cultured; D002648:Child; D002675:Child, Preschool; D003176:Complement C3 / Q000235:genetics; D011415:Complement Factor B / Q000235:genetics; D017242:Complement Factor H / Q000235:genetics*; D003170:Complement Pathway, Alternative / Q000235:genetics*; D003715:Dengue / Q000235:genetics* / Q000276:immunology*; D003716:Dengue Virus; D005260:Female; D056726:Genetic Association Studies; D020022:Genetic Predisposition to Disease; D006801:Humans; D008297:Male; D008875:Middle Aged; D011110:Polymorphism, Genetic; D013785:Thailand; D055815:Young Adult
chemical_list: D003176:Complement C3; D017242:Complement Factor H; D011415:Complement Factor B
keywords: Dengue infection; alternative complement pathway; genetic polymorphism
references.citation: Proc Natl Acad Sci U S A. 2005 May 17;102(20):7227-32
references.pmid: 15870199
references.citation: Invest Ophthalmol Vis Sci. 2009 Nov;50(11):5070-9
references.pmid: 19553609
references.citation: J Exp Med. 2010 Apr 12;207(4):793-806
references.pmid: 20308361
references.citation: Microbes Infect. 2009 Feb;11(2):143-56
references.pmid: 19121645
references.citation: Vaccine. 2008 Dec 30;26 Suppl 8:I100-7
references.pmid: 19388173
references.citation: Science. 2010 May 7;328(5979):745-8
references.pmid: 20448183
references.citation: Invest Ophthalmol Vis Sci. 2009 Dec;50(12):5818-27
references.pmid: 19661236
references.citation: Hum Immunol. 2013 Sep;74(9):1225-30
references.pmid: 23747994
references.citation: Hum Mol Genet. 2008 Apr 1;17(7):971-7
references.pmid: 18084039
references.citation: J Infect Dis. 2002 Oct 15;186(8):1165-8
references.pmid: 12355369
references.citation: Immunol Cell Biol. 2003 Jun;81(3):196-206
references.pmid: 12752684
references.citation: J Virol. 2009 May;83(10):4766-77
references.pmid: 19264772
references.citation: Nat Med. 2003 Jul;9(7):921-7
references.pmid: 12808447
references.citation: Cell Host Microbe. 2007 Dec 13;2(6):417-26
references.pmid: 18078693
references.citation: Blood. 2010 Jan 14;115(2):379-87
references.pmid: 19861685
references.citation: Nat Genet. 2005 May;37(5):507-13
references.pmid: 15838506
references.citation: Biochem Biophys Res Commun. 2007 Nov 3;362(4):1051-6
references.pmid: 17825259
references.citation: PLoS One. 2009 Aug 26;4(8):e6782
references.pmid: 19707565
references.citation: Proc Natl Acad Sci U S A. 2011 May 24;108(21):8761-6
references.pmid: 21555552
references.citation: Ann Med. 2006;38(8):592-604
references.pmid: 17438673
references.citation: N Engl J Med. 2007 Aug 9;357(6):553-61
references.pmid: 17634448
references.citation: J Infect Dis. 2006 Apr 15;193(8):1078-88
references.pmid: 16544248
references.citation: Mol Vis. 2011;17:2080-92
references.pmid: 21850184
references.citation: Trans Assoc Am Physicians. 1973;86:102-10
references.pmid: 4132983
references.citation: Nat Genet. 2011 Mar 13;43(4):321-7
references.pmid: 21399633
references.citation: Proc Natl Acad Sci U S A. 2006 Dec 12;103(50):19111-6
references.pmid: 17132743
references.citation: Am J Trop Med Hyg. 1989 Apr;40(4):418-27
references.pmid: 2540664
references.citation: PLoS Genet. 2011 May;7(5):e1002079
references.pmid: 21637784
references.citation: Nat Genet. 2006 Apr;38(4):458-62
references.pmid: 16518403
references.citation: Hum Mol Genet. 2010 Dec 1;19(23):4694-704
references.pmid: 20843825